By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more
Turnout in the village of Ephraim reached 89% in 2020. Photo by Myles Dannhausen Jr. If history repeats and Door County voters have called the presidential election as they have seven times straight since 1996, Kamala Harris will be the next president of the United States. That’s of course not official – there was a … Read more
Gallagher’s Q3 results reveal steady growth in key segments | Insurance Business America Insurance News Gallagher’s Q3 results reveal steady growth in key segments Organic expansion and new mergers sustain revenue increases across sectors Insurance News By Kenneth Araullo Arthur J Gallagher & Co (Gallagher) has released its financial results for Q3, ending September 30, … Read more
By Brad Sorensen, CFA NASDAQ:MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic cannabinoid analog for the treatment of adult patients with neuropathic pain as well as anxiety and cognitive decline typically associated with early-stage dementia. The company … Read more
By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT BioStem Technologies, Inc. (OTC:BSEM) is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The company states its mission is “to discover, develop and produce the most effective regenerative medicine … Read more
